Abstract 3598: A first-in-class tri-complex KRASG13C(ON) inhibitor validates therapeutic targeting of KRASG13Cand drives tumor regressions in preclinical models

Name: Work Video:
Duration: 3 min 30 s
Christopher J. Schulze; Jim Cregg; Kyle J. Seamon; Yu Chi Yang; Zhican Wang; Lindsay S. Garrenton; Alun Bermingham; John E. Knox; Aidan C.A. Tomlinson; Kang-Jye Chou; Shaoling Li; David Wildes; Mallika Singh; Elena S. Koltun; Adrian L. Gill; Robert J. Nichols; Jacqueline A.M. Smith
{'id': 'https://openalex.org/W4282976492', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-3598', 'title': 'Abstract 3598: A first-in-class tri-complex KRASG13C(ON) inhibitor validates therapeutic targeting of KRASG13Cand drives tumor regressions in preclinical models', 'display_name': 'Abstract 3598: A first-in-class tri-complex KRASG13C(ON) inhibitor validates therapeutic targeting of KRASG13Cand drives tumor regressions in preclinical models', 'publication_year': 2022, 'publication_date': '2022-06-15', 'ids': {'openalex': 'https://openalex.org/W4282976492', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-3598'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-3598', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5052945974', 'display_name': 'Christopher J. Schulze', 'orcid': 'https://orcid.org/0009-0005-6736-871X'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christopher J. Schulze', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078573857', 'display_name': 'Jim Cregg', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jim Cregg', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039694843', 'display_name': 'Kyle J. Seamon', 'orcid': 'https://orcid.org/0009-0005-5028-3752'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kyle J. Seamon', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020727899', 'display_name': 'Yu Chi Yang', 'orcid': 'https://orcid.org/0000-0001-8318-1174'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yu Chi Yang', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055357640', 'display_name': 'Zhican Wang', 'orcid': 'https://orcid.org/0000-0002-9411-9349'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Zhican Wang', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058881772', 'display_name': 'Lindsay S. Garrenton', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lindsay S. Garrenton', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071778044', 'display_name': 'Alun Bermingham', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Alun Bermingham', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041603099', 'display_name': 'John E. Knox', 'orcid': 'https://orcid.org/0009-0006-6246-5198'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John E. Knox', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054021851', 'display_name': 'Aidan C.A. Tomlinson', 'orcid': 'https://orcid.org/0000-0002-9663-773X'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Aidan Tomlinson', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002869939', 'display_name': 'Kang-Jye Chou', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kang-Jye Chou', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026492211', 'display_name': 'Shaoling Li', 'orcid': 'https://orcid.org/0000-0002-7621-3091'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Shaoling Li', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038156337', 'display_name': 'David Wildes', 'orcid': 'https://orcid.org/0009-0009-3855-7270'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David P. Wildes', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057362852', 'display_name': 'Mallika Singh', 'orcid': 'https://orcid.org/0009-0003-0234-1589'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mallika Singh', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040036103', 'display_name': 'Elena S. Koltun', 'orcid': 'https://orcid.org/0009-0005-8720-9097'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Elena S. Koltun', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022776516', 'display_name': 'Adrian L. Gill', 'orcid': 'https://orcid.org/0009-0003-0914-4860'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Adrian L. Gill', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103986436', 'display_name': 'Robert J. Nichols', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Robert J. Nichols', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5027330002', 'display_name': 'Jacqueline A.M. Smith', 'orcid': 'https://orcid.org/0000-0001-5028-8725'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jacqueline A. Smith', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.899, 'has_fulltext': False, 'cited_by_count': 7, 'citation_normalized_percentile': {'value': 0.999981, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 87, 'max': 88}, 'biblio': {'volume': '82', 'issue': '12_Supplement', 'first_page': '3598', 'last_page': '3598'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12620', 'display_name': 'Signaling Pathways in Disease', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12620', 'display_name': 'Signaling Pathways in Disease', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12505', 'display_name': 'Peptidase Inhibition and Analysis', 'score': 0.9975, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11041', 'display_name': 'Ubiquitin and proteasome pathways', 'score': 0.9956, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.53875214}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.48074937}, {'id': 'https://openalex.org/C51785407', 'wikidata': 'https://www.wikidata.org/wiki/Q2627568', 'display_name': 'Effector', 'level': 2, 'score': 0.46624368}, {'id': 'https://openalex.org/C79879829', 'wikidata': 'https://www.wikidata.org/wiki/Q5571762', 'display_name': 'Intracellular', 'level': 2, 'score': 0.4502071}, {'id': 'https://openalex.org/C143065580', 'wikidata': 'https://www.wikidata.org/wiki/Q3285695', 'display_name': 'Mutant', 'level': 3, 'score': 0.44491497}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.383637}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.33374602}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.32562315}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-3598', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.82, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4380992933', 'https://openalex.org/W4320492283', 'https://openalex.org/W4309090929', 'https://openalex.org/W4214695225', 'https://openalex.org/W3197607994', 'https://openalex.org/W3020059968', 'https://openalex.org/W2783284266', 'https://openalex.org/W2171209136', 'https://openalex.org/W2155835698', 'https://openalex.org/W1530034981'], 'abstract_inverted_index': {'Abstract': [0], 'The': [1, 175], 'clinical': [2, 391], 'activity': [3, 244], 'of': [4, 21, 66, 93, 101, 112, 124, 153, 186, 213, 234, 241, 262, 307, 311, 320, 338, 369, 388, 447, 458], 'KRASG12C(OFF)': [5], 'inhibitors': [6, 69, 82, 276], 'has': [7], 'validated': [8], 'KRASG12C': [9], 'as': [10, 351], 'an': [11, 200, 305, 347, 376], 'oncogenic': [12, 30, 118], 'driver': [13], 'in': [14, 38, 50, 53, 137, 221, 249, 325, 379, 452], 'human': [15], 'cancers': [16], 'and': [17, 63, 75, 105, 114, 120, 140, 149, 165, 190, 217, 238, 245, 272, 279, 281, 345], 'demonstrated': [18], 'the': [19, 51, 61, 91, 121, 131, 138, 196, 283, 308, 372, 386, 459], 'power': [20], 'targeting': [22, 134, 446], 'cysteine': [23, 32], 'mutations': [24], 'with': [25, 44, 86, 155, 193, 302, 343, 371, 381], 'covalent': [26, 151, 191], 'inhibitors.': [27], 'A': [28, 167, 439], 'second': [29], 'RAS': [31, 187, 214, 242, 328, 357], 'mutation,': [33, 322], 'KRASG13C,': [34], 'is': [35, 58, 146, 292, 362], 'found': [36], 'predominantly': [37], 'non-small': [39], 'cell': [40, 219, 225], 'lung': [41], 'cancer': [42, 224], '(NSCLC),': [43], '&amp;gt;': [45], '2,700': [46], 'new': [47], 'cases': [48], 'reported': [49], 'USA': [52], '2020': [54], 'but': [55], 'relatively': [56], 'little': [57], 'known': [59], 'about': [60], 'biochemical': [62], 'cellular': [64], 'properties': [65, 111], 'KRASG13C.': [67, 102], 'KRASG12C-selective': [68], 'are': [70, 78], 'not': [71], 'active': [72], 'against': [73], 'KRASG13C': [74, 113, 125, 135, 222, 228, 257, 287, 291, 312, 341, 382], 'currently': [76], 'there': [77], 'no': [79], 'direct,': [80], 'targeted': [81], 'available': [83], 'for': [84, 133, 285, 462], 'patients': [85, 380], 'KRASG13C-driven': [87], 'cancers.': [88], 'We': [89], 'report': [90], 'development': [92], 'a': [94, 147, 161, 169, 259, 317, 335, 363], 'potent,': [95], 'selective,': [96], 'orally': [97], 'bioavailable': [98], 'tri-complex': [99, 162, 178, 441], 'inhibitor': [100, 152, 368, 443], 'Using': [103], 'chemical': [104], 'genetic': [106], 'approaches,': [107], 'we': [108], 'describe': [109], 'unique': [110], 'their': [115], 'influence': [116], 'on': [117, 269], 'signaling': [119, 182], 'co-mutational': [122, 309], 'landscape': [123, 310], 'mutant': [126, 223, 339, 383], 'tumors.': [127], 'These': [128], 'insights': [129], 'provide': [130], 'basis': [132], 'NSCLC': [136], 'clinic': [139], 'shape': [141], 'future': [142], 'combination': [143, 332], 'strategies.': [144], 'RM-041': [145, 159, 206, 235, 344, 361, 389], 'potent': [148], 'selective': [150, 340], 'KRASG13C(ON)': [154, 164, 181, 370, 442], 'attractive': [156], 'drug-like': [157], 'properties.': [158], 'forms': [160], 'between': [163], 'cyclophilin': [166], '(CypA),': [168], 'highly': [170], 'abundant': [171], 'intracellular': [172], 'chaperone': [173], 'protein.': [174], 'assembled': [176], 'non-covalent': [177], 'rapidly': [179], 'prevents': [180], 'via': [183], 'steric': [184], 'blockade': [185], 'effector': [188], 'binding,': [189], 'engagement': [192], 'Cys-13': [194], 'converts': [195], 'inactive': [197], 'assembly': [198], 'into': [199], 'irreversibly': [201], 'inhibited': [202], 'complex.': [203], 'In': [204, 227, 289, 300, 359], 'cells,': [205], 'covalently': [207], 'modifies': [208], 'KRASG13C(ON),': [209], 'drives': [210, 449], 'deep': [211, 237], 'suppression': [212, 240], 'pathway': [215, 243], 'signaling,': [216], 'inhibits': [218], 'proliferation': [220], 'lines.': [226], 'xenograft': [229], 'tumor': [230, 247, 314, 450], 'models,': [231], 'oral': [232], 'administration': [233], 'produces': [236], 'durable': [239], 'induces': [246], 'regressions': [248, 451], 'vivo': [250], 'at': [251], 'well-tolerated': [252], 'doses.': [253], 'Compared': [254], 'to': [255, 274, 295, 353, 374], 'KRASG12C,': [256], 'exhibits': [258], 'higher': [260], 'rate': [261], 'spontaneous': [263], 'nucleotide': [264], 'exchange,': [265], 'reducing': [266], 'its': [267], 'dependence': [268], 'GEF': [270], 'reloading': [271], 'sensitivity': [273], 'upstream': [275, 348], '(e.g.,': [277], 'SHP2': [278], 'SOS1)': [280], 'underscoring': [282], 'need': [284, 378], 'direct': [286], 'inhibition.': [288], 'addition,': [290], 'uniquely': [293], 'sensitive': [294], 'select': [296], 'GAPs,': [297], 'including': [298], 'NF1.': [299], 'line': [301], 'this': [303], 'observation,': [304], 'analysis': [306], 'patient': [313], 'samples': [315], 'revealed': [316], 'high': [318], 'prevalence': [319], 'NF1LOF': [321], 'likely': [323], 'resulting': [324], 'enhanced': [326], 'wild-type': [327, 356], 'signaling.': [329, 358], 'Our': [330], 'preclinical': [331, 453], 'data': [333], 'support': [334], 'therapeutic': [336, 445], 'strategy': [337], 'inhibition': [342], 'co-targeting': [346], 'node,': [349], 'such': [350], 'SHP2,': [352], 'attenuate': [354], 'cooperative': [355], 'summary,': [360], 'first-in-class,': [364], 'mutant-selective,': [365], 'oral,': [366], 'tricomplex': [367], 'potential': [373], 'address': [375], 'unmet': [377], 'cancer,': [384], 'supporting': [385], 'advancement': [387], 'towards': [390], 'evaluation.': [392], 'Citation': [393], 'Format:': [394], 'Christopher': [395], 'J.': [396, 401, 434], 'Schulze,': [397], 'Jim': [398], 'Cregg,': [399], 'Kyle': [400], 'Seamon,': [402], 'Yu': [403], 'Chi': [404], 'Yang,': [405], 'Zhican': [406], 'Wang,': [407], 'Lindsay': [408], 'S.': [409, 428], 'Garrenton,': [410], 'Alun': [411], 'Bermingham,': [412], 'John': [413], 'E.': [414], 'Knox,': [415], 'Aidan': [416], 'Tomlinson,': [417], 'Kang-Jye': [418], 'Chou,': [419], 'Shaoling': [420], 'Li,': [421], 'David': [422], 'P.': [423], 'Wildes,': [424], 'Mallika': [425], 'Singh,': [426], 'Elena': [427], 'Koltun,': [429], 'Adrian': [430], 'L.': [431], 'Gill,': [432], 'Robert': [433], 'Nichols,': [435], 'Jacqueline': [436], 'A.': [437], 'Smith.': [438], 'first-in-class': [440], 'validates': [444], 'KRASG13Cand': [448], 'models': [454], '[abstract].': [455], 'In:': [456], 'Proceedings': [457], 'American': [460], 'Association': [461], 'Cancer': [463, 474], 'Research': [464], 'Annual': [465], 'Meeting': [466], '2022;': [467], '2022': [468], 'Apr': [469], '8-13.': [470], 'Philadelphia': [471], '(PA):': [472], 'AACR;': [473], 'Res': [475], '2022;82(12_Suppl):Abstract': [476], 'nr': [477], '3598.': [478]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4282976492', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 4}, {'year': 2022, 'cited_by_count': 1}], 'updated_date': '2024-12-25T02:35:28.850449', 'created_date': '2022-06-17'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
